JPMorgan Chase & falls 4.2% after Senate probe reports coincide with broad market sell-off

What happened

JPMorgan Chase & (JPM) fell 4.2% on November 5, 2026, after reports said Senate Finance Committee Democrats were preparing a probe of the bank's ties to Jeffrey Epstein, as markets sold off. The S&P 500 fell 4.4%, and the Financial Services sector median fell 1.9%. Trading in the stock was heavy, with volume at 1.8 times its 20-day average.

How big was the move

The move was large relative to history and peers. The session represented 3.3 times a typical daily move for the stock, and the stock underperformed its sector by 2.3 percentage points. Over the last five sessions the stock fell 1.8%, while the S&P 500 fell 4.7% over the same period, suggesting part of the decline tracked broader market weakness and part reflected company-specific news. In the past five years the stock had 14 sessions with a decline of at least 4.2%; twenty trading days later the median result was a gain of 1.6%, and nine of 14 were higher.

The technical picture

At the close the stock was 0.1% above its 20-day moving average and 1.4% below its 50-day moving average. The 50-day average was above the 200-day average, a sign of an established uptrend, and the stock had been above its 200-day average for 108 consecutive trading days. Distance from the 52-week high stood at 8.0% below the 52-week high, and the Relative Strength Index (14 days) read 49, in a neutral range. Volatility was 20% annualized over 60 days, lower than 66% of its own readings over five years.

Fundamentals and valuation

For the four quarters through September 30, 2026, revenue was $301.92 billion, which grew 8.7% from a year earlier. Diluted earnings per share were $23.84, and earnings per share growth from a year earlier rose 18.1%. Gross margin improved to 63.2% from 60.2% a year earlier, and operating margin was 28.2% compared with 26.2% a year earlier. The balance sheet showed net debt of 9.8 times EBITDA and share count over one year decreased by 3.1%.

The stock traded at 14.2 times trailing earnings and 13.6 times expected earnings. That valuation is higher than 76% of its own readings over the past five years, with a five-year median of 11.6 times earnings. PromtFinance scores ranked the company 28 for Value (Very weak) and 76 for Growth (Positive), with Quality at 35 (Weak) and Stability at 27 (Very weak).

Earnings and analyst expectations

The last report, on October 13, 2026, showed earnings per share of $5.75 against $5.93 expected, 3.0% below estimates. The company had 0 consecutive quarters beating estimates, though average surprise over the last four reports was 9.7% above estimates. The typical two-day reaction after recent reports was unchanged. Analysts' consensus rating was Buy, with a consensus price target of $373.36, which is 10.7% above the closing price. Of the 61 analysts covering the stock, 52% rate it as Buy or Strong Buy. The next report was scheduled for January 12, 2027.

What to watch

• November 5, 2026: news reports by CNBC and Barrons about a Senate Finance Committee inquiry into the bank's ties to Jeffrey Epstein and how senior executives handled those relationships.
• January 12, 2027: next scheduled earnings report.
• October 13, 2026: last earnings report with EPS of $5.75, 3.0% below estimates.
• Ongoing market conditions: the S&P 500 fell 4.4% on the same day and was down 4.7% over five sessions, indicating broader market pressure.